NeuralPLexer3: Accurate Biomolecular Complex Structure Prediction with Flow Models
Zhuoran Qiao, Feizhi Ding, Thomas Dresselhaus, Mia A. Rosenfeld, Xiaotian Han, Owen Howell, Aniketh Iyengar, Stephen Opalenski, Anders S. Christensen, Sai Krishna Sirumalla, Frederick R. Manby, Thomas F. Miller, Matthew Welborn
TL;DR
NeuralPLexer3 (NP3) tackles the challenge of accurate biomolecular complex structure prediction, including ligand-induced conformational changes, by employing a physics-informed flow-based model with continuous normalizing flows and flow matching. The method integrates a globular polymer prior, symmetry-corrected prior alignment, and an anchored encoder–decoder architecture to enable fast, high-fidelity sampling of multi-molecule assemblies. NP3 delivers state-of-the-art accuracy on protein–ligand complexes and broad coverage across nucleic acids, covalent modifications, and protein–protein interactions, while achieving substantial speed-ups over prior diffusion-based approaches. The framework is validated through new benchmarks (NPBench and ConfBench) and shows practical promise for target validation, structural hypothesis generation, and atom-level interaction analysis in drug discovery, with efficient operation on standard hardware.
Abstract
Structure determination is essential to a mechanistic understanding of diseases and the development of novel therapeutics. Machine-learning-based structure prediction methods have made significant advancements by computationally predicting protein and bioassembly structures from sequences and molecular topology alone. Despite substantial progress in the field, challenges remain to deliver structure prediction models to real-world drug discovery. Here, we present NeuralPLexer3 -- a physics-inspired flow-based generative model that achieves state-of-the-art prediction accuracy on key biomolecular interaction types and improves training and sampling efficiency compared to its predecessors and alternative methodologies. Examined through newly developed benchmarking strategies, NeuralPLexer3 excels in vital areas that are crucial to structure-based drug design, such as physical validity and ligand-induced conformational changes.
